DXCM Dexcom margins

Relative Growth: Rel. Growth: 92

Relative Strength: Rel. Strength: 76

Relative Valuation: Rel. Valuation: 43

Relative Profitability: Rel. Profitability: 94

Gross margin

63.4%

Operating margin

24%

EBITDA margin

30.5%

Net margin

19.4%

Recent Dexcom shows a gross margin of 63.4%, an operating margin of 24%, an EBITDA margin of 30.5%, and a net margin of 19.4%. All measured margins increased year over year, led by operating margin with an increase of 6.8 percentage points.

DXCM margin history

Gross, operating, EBITDA and net margin trends

Over the last 3 years, Dexcom's margins averaged 61.3% gross, 18.18% operating, 26.86% EBITDA, and 16.58% net. All four current margins are above their three-year averages.

DXCM margin expansion

Year-over-year margin changes in percentage points

The biggest expansion was in operating margin, which rose by 6.8 percentage points. The other available margins also improved.

Gross margin expansion

4.4pp

Operating margin expansion

6.8pp

EBITDA margin expansion

3.4pp

Net margin expansion

3.4pp

DXCM Gross margin

Dexcom's gross margin averaged 61.3% in the last 3 years. The latest gross margin for Dexcom is 63.4%, 2.1 percentage points above its three-year average. Over the last 3 years, Dexcom's gross margin peaked at 63.4% in Sep 2026 and reached a low of 58.8% in Jun 2025.

DXCM Operating margin

Dexcom's operating margin averaged 18.18% over the last 3 years. Compared with its three-year average, Dexcom's current operating margin is 24% and is 5.8 percentage points above its three-year average. Over the last 3 years, Dexcom's operating margin peaked at 24% in Sep 2026 and reached a low of 14.9% in Dec 2024.

DXCM EBITDA margin

Across the last 3 years, Dexcom's EBITDA margin came to 26.86%. Dexcom currently reports an EBITDA margin of 30.5%, 3.6 percentage points above its three-year average. EBITDA margin was highest at 31.4% in Jun 2026 and lowest at 23.4% in Dec 2024.

DXCM Net margin

Over the last 3 years, Dexcom's net margin averaged 16.58%. The current net margin of 19.4% is 2.8 percentage points above its three-year average. During this period, net margin reached a high of 20.1% in Jun 2026 and a low of 12.9% in Mar 2025.

DXCM margin group comparison

Margins compared with peer-group, industry and sector averages

With a gross margin of 63.4%, DXCM stands higher than the industry and its peers average but lower than the Healthcare sector average. Looking at the Healthcare sector average of 68.3%, Dexcom's gross margin is 7% lower.

DXCM margin peer comparison

Compare margins with selected peers

Frequently asked questions

What is Dexcom's gross margin?

The current gross margin for DXCM is 63.4% as of Sep 30, 2026.

What is Dexcom's operating margin?

As of Sep 30, 2026, DXCM has an operating margin of 24%.

What is Dexcom's EBITDA margin?

The current EBITDA margin for DXCM is 30.5% as of Sep 30, 2026.

What is Dexcom's net margin?

For the period ending Sep 30, 2026, DXCM recorded a net margin of 19.4%.

What are the average margins of DXCM?

The three-year average margins for DXCM were 61.3% gross, 18.2% operating, 26.9% EBITDA, and 16.6% net.

What are the highest historical margins of DXCM?

Dexcom's highest recorded margins during the past 5 years were 68.6% gross in Dec 2021, 24% operating in Sep 2026, 31.4% EBITDA in Jun 2026, and 20.1% net in Jun 2026.

What are the lowest historical margins of DXCM?

Looking back across 5 years, DXCM reached its lowest margins at 58.8% gross in Jun 2025, 8.9% operating in Jun 2022, 14.5% EBITDA in Jun 2022, and 8.6% net in Jun 2022.